GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 263 filers reported holding GLOBUS MED INC in Q4 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,360,000 | +10.2% | 203,408 | -20.3% | 0.13% | -4.4% |
| Q3 2017 | $7,587,000 | -45.3% | 255,273 | -38.9% | 0.14% | -53.9% |
| Q2 2017 | $13,859,000 | +17.8% | 418,079 | +5.2% | 0.30% | +13.5% |
| Q1 2017 | $11,769,000 | +326.0% | 397,308 | +256.7% | 0.26% | +209.5% |
| Q4 2016 | $2,763,000 | -30.2% | 111,373 | -36.5% | 0.08% | -42.9% |
| Q3 2016 | $3,957,000 | -16.9% | 175,322 | -12.2% | 0.15% | -42.8% |
| Q2 2016 | $4,760,000 | +609.4% | 199,725 | +606.5% | 0.26% | +511.9% |
| Q1 2016 | $671,000 | -55.8% | 28,268 | -48.2% | 0.04% | -64.4% |
| Q4 2015 | $1,519,000 | +5.9% | 54,592 | -21.4% | 0.12% | -48.2% |
| Q3 2015 | $1,434,000 | -75.9% | 69,414 | -70.0% | 0.23% | -3.8% |
| Q2 2015 | $5,946,000 | +2.1% | 231,608 | +0.4% | 0.24% | +1.7% |
| Q1 2015 | $5,824,000 | +16.5% | 230,758 | +9.7% | 0.23% | -9.7% |
| Q4 2014 | $4,998,000 | -5.9% | 210,264 | -22.2% | 0.26% | -37.4% |
| Q3 2014 | $5,313,000 | – | 270,124 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |